Trial Profile
The effect of experimental hyperglycemia and AT1 [angiotensin II type 1] [valsartan] receptor blockade on renal hemodynamics in impaired glucose tolerance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Glucose intolerance
- Focus Pharmacodynamics
- 18 Jan 2008 New trial record.